METHYLTETRAHYDRO-β-CARBOLINES AND PARKINSON'S DISEASE
- 1 June 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8440) , 1272-1273
- https://doi.org/10.1016/s0140-6736(85)92338-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Brain Enzyme Is the Target of Drug ToxinScience, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Benzodiazepine antagonism by harmane and other β-carbolines in vitro and in vivoEuropean Journal of Pharmacology, 1981
- Actions of tetrahydronorharmane (tetrahydro-β-carboline) on 5-hydroxytryptamine and dopamine mediated mechanismsNeuropharmacology, 1981
- 6-Hydroxy-tetrahydronorharmane (6-hydroxy-tetrahydro-?-carboline), a new active metabolite of indole-alkylamines in man and ratNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Tryptoline Formation by a Preparation from Brain with 5-Methyltetrahydrofolic Acid and TryptamineScience, 1975
- Monoamine Oxidase InhibitorsJournal of Pharmaceutical Sciences, 1972